Acadia Healthcare Company, Inc. ACHC
Nasdaq · XNAS · stock · Services-Specialty Outpatient Facilities, NEC
Chart by TradingView
5/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $3.3B | -$1.1B | — | -$439.9M | $1.9B |
| 2024 | $3.2B | $255.6M | — | -$560.7M | $3.1B |
| 2023 | $2.9B | -$21.7M | — | $38.2M | $2.8B |
| 2022 | $2.6B | $273.1M | — | $84.4M | $2.8B |
| 2021 | $2.3B | $190.6M | — | $129.4M | $2.5B |
| 2020 | $2.1B | -$672.1M | — | $277.9M | $1.9B |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0001520697 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.